Terumo Neuro
Kyle Obradovich is an experienced medical sales professional with a robust background in territory management and business development. Currently serving as a Territory Manager at MicroVention-Terumo since September 2023, Kyle previously held the position of Business Manager for Florida at Balt and served as a Senior Vascular Territory Manager at BD for eight years. Earlier in the career, Kyle worked as a Reconstructive Orthopedic Sales Representative at Stryker and as a Neuro and Orthopedic Sales Representative at PMT Corporation. Notable achievements include consistently exceeding sales quotas and generating significant growth in various roles. Kyle holds a Bachelor of Science degree from Kent State University, earned between 2001 and 2006.
This person is not in any offices
Terumo Neuro
1 followers
A global leader in neurovascular innovation, MicroVention is now Terumo Neuro. This name change signifies a new chapter in the company’s evolution while maintaining its unwavering commitment to the creation and commercialization of groundbreaking innovations in neurovascular care. We are in business to create and deliver Game-changing Impact™—innovations that redefine what is possible in neuroendovascular treatment to meaningfully advance both physician practice and patient outcomes. Founded in 1997 as MicroVention and acquired by Terumo Corporation in 2006, Terumo Neuro offers more than thirty products for the treatment of cerebral aneurysms, ischemic stroke, carotid artery disease, and neurovascular malformations. Headquartered in California, Terumo Neuro products are sold in more than seventy countries through a direct sales organization as well as strategic distribution partnerships. Manufacturing facilities are in Aliso Viejo, California, and San José, Costa Rica.